/Labcorp%20Holdings%20Inc_%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
With a market cap of $19.2 billion, Labcorp Holdings Inc. (LH) is a leading global life sciences company specializing in diagnostic testing and drug development services. The Burlington, North Carolina-based company provides comprehensive healthcare solutions, including laboratory testing, clinical trials, and research support, serving clients in various industries worldwide.
Companies valued at $10 billion or more are classified as "large-cap" stocks. Labcorp Holdings fits right into this category, showcasing its substantial scale, stability, and leadership in the healthcare and diagnostics sector. Its market leadership stems from its expansive diagnostic testing capabilities, robust clinical trial services, and strong global presence. The company leverages cutting-edge technology and an extensive network to deliver reliable, high-quality testing solutions to healthcare providers and patients.